We’re developing safe, effective drugs to combat bioterrorism and infectious disease.
Emerging biological and chemical threats pose a significant risk to national security and public health.
Governments everywhere are increasingly vigilant and investing billions of dollars in preparation for potential bioterrorism attacks and pandemic diseases.
AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally occurring infectious diseases.
Our growing portfolio responds to the demand for safe, effective therapeutics for national stockpiles against a range of threats from weaponized toxic agents such as the ricin and sarin to viruses such as Ebola.